The Brand Name RETILONE Has Generic Salt :: Triamcinolone
RETILONE Is From Company Cipla Priced :: Rs. 100
RETILONE have Triamcinolone is comes under Sub class Mouth,Ear Preparations of Main Class Ear
Main Medicine Class:: Ear Sub Medicine Class :: Mouth,Ear Preparations
|Salt Name : OR Generic Name||Form||Price : MRP /Probable||Packing|
Indications for Drugs ::
Allergic and inflammatory responses, Inflammatory joint disease, Inflammatory skin conditions
Drug Dose ::
Adult: IM Allergic and inflammatory responses As acetonide: 20-80 mg. Hay fever As acetonide: 40-100 mg. Intra-articular Inflammatory joint disease As acetonide: Smaller joints: 2.5-5 mg (up to 10 mg), larger joints: 5-15 mg (up to 40 mg). Max: 20-80 mg/treatment. Children 6 to 12 years: initial dose is 40 mg. Adults and children over 12 years of age: initial dose is 60 mg. Dosage is usually adjusted within the range of 40 to 80 mg. For local areas, dose for adults is up to 10 mg for smaller areas and up to 40 mg for larger areas.
Triamcinolone Acetonide is contraindicated in patients with a sensitivity to the active or inactive ingredients. Untreated systemic fungal, bacterial, viral or parasitic infection, hypersensitivity. Neonates (Parenteral)
Drug Precautions ::
Triamcinolone Acetonide should be used cautiously in patients with ocular herpes simplex, nonspecific ulcerative colitis, active or latent peptic ulcer, renal insufficiency, hypertension, osteoporosis, Cushing’s syndrome, diabetes mellitus, congestive heart failure, chronic nephritis.
Drug Side Effects ::
Cushingoid syndrome, weakness, bruising or purpura, aggravation of infections, peptic ulcer, glaucoma; hyperglycaemia; GI upsets; increased appetite; increased fragility of skin; behavioural changesm activation of latent or aggravation of existing diabetes, altered menstrual cycle, hirsutism.
Pregnancy category ::
Drug Mode of Action ::
Triamcinolone has mainly glucocorticoid activity. It suppresses the migration of polymorphonuclear leukocytes and reduces capillary permeability thereby decreasing inflammation.
Drug Interactions ::
Lowering of plasma salicylates levels. Increased risk of GI bleeding and ulceration with NSAIDs. Antagonised blood glucose-lowering effects of the antidiabetics. Increased risk of hyperkalaemia with amphotericin B, ? agonists, ?-blockers, potassium-depleting diuretics, theophylline. Increased clearance of the triamcinolone with ciclosporin, carbamazepine, phenytoin, barbiturate, rifampicin. Infections may develop if given with live vaccines.